SCD1-Fatty Acid Desaturase Inhibitor MF-438 Alleviates Latent Inflammation Induced by Preservative-Free Prostaglandin Analog Eye Drops

References

• Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183–2193. doi:10.1016/S0140-6736(17)31469-1
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911. doi:10.1001/jama.2014.3192
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312–334. doi:10.1016/j.preteyeres.2010.03.001
   PubMed Web of Science ®Google Scholar
• Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86(7):716–726. doi:10.1111/j.1755-3768.2008.01250.x
   PubMed Web of Science ®Google Scholar
• Kim SH, Kwon D, Lee S, et al. Concentration-and time-dependent effects of benzalkonium chloride in human lung epithelial cells: necrosis, apoptosis, or epithelial mesenchymal transition. Toxics. 2020;8(1). doi:10.3390/toxics8010017
   Web of Science ®Google Scholar
• Trzeciecka A, Paterno JJ, Toropainen E, et al. Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa. Eur J Pharmacol. 2016;788:12–20. doi:10.1016/j.ejphar.2016.06.014
   PubMed Web of Science ®Google Scholar
• Smedowski A, Paterno JJ, Toropainen E, Sinha D, Wylegala E, Kaarniranta K. Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells. J Biochem Pharmacol Res. 2014;2(4):175–184. doi:10.1016/j.pestbp.2011.02.012
   PubMedGoogle Scholar
• Kim JH, Kim EJ, Kim YH, et al. In vivo effects of preservative-free and preserved prostaglandin analogs: Mouse Ocular Surface Study. Korean J Ophthalmol. 2015;29(4):270–279. doi:10.3341/kjo.2015.29.4.270
   PubMedGoogle Scholar
• Juretić M, Cetina-čižmek B, Filipović-Grčić J, Hafner A, Lovrić J, Pepić I. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. Eur J Pharm Sci. 2018;120:133–141. doi:10.1016/j.ejps.2018.04.032
   PubMed Web of Science ®Google Scholar
• Wallner S, Grandl M, Konovalova T, et al. Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation. PLoS One. 2014;9(4):e94102. doi:10.1371/journal.pone.0094102
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. doi:10.1038/nature05485
   PubMed Web of Science ®Google Scholar
• Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016;Volume 10:2433–2441. doi:10.2147/OPTH.S118409
   Google Scholar
• Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). In: Ocular Surface. Vol. 5. ETHIS COMMUNICATIONS, INC.; 2007:75–92. doi:10.1016/s1542-0124(12)70081-2
   Google Scholar
• Hassan W, Ding L, Gao RY, Liu J, Shang J. Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine. 2014. doi:10.1016/j.cyto.2013.12.017
   Web of Science ®Google Scholar
• Taylor R, Jones A, Kelly S, Simpson M, Mabey J. A review of the value of procalcitonin as a marker of infection. Cureus. 2017;9(4). doi:10.7759/cureus.1148
   Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. doi:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Lee KY. M1 and M2 polarization of macrophages: a mini-review. Med Biol Sci Eng. 2019;2(1):1–5. doi:10.30579/mbse.2019.2.1.1
   Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6. doi:10.12703/P6-13
   PubMedGoogle Scholar
• Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090. doi:10.1016/j.ejphar.2020.173090
   PubMed Web of Science ®Google Scholar
• Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(Lps+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages. Front Immunol. 2019;10(MAY). doi:10.3389/fimmu.2019.01084
   PubMed Web of Science ®Google Scholar
• Liu X, Strable MS, Ntambi JM. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv Nutr. 2011;2(1):15–22. doi:10.3945/an.110.000125
   PubMed Web of Science ®Google Scholar
• Thörn K, Hovsepyan M, Bergsten P. Reduced levels of SCD1 accentuate palmitate-induced stress in insulin-producing β-cells. Lipids Health Dis. 2010;9(1):108. doi:10.1186/1476-511X-9-108
   PubMed Web of Science ®Google Scholar
• MacDonald MLE, Van Eck M, Hildebrand RB, et al. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29(3):341–347. doi:10.1161/ATVBAHA.108.181099
   PubMed Web of Science ®Google Scholar
• Peter A, Weigert C, Staiger H, et al. Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity. Am J Physiol Endocrinol Metab. 2008;295(2):E339–E349. doi:10.1152/ajpendo.00022.2008
   PubMed Web of Science ®Google Scholar
• Hulver MW, Berggren JR, Carper MJ, et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2005;2(4):251–261. doi:10.1016/j.cmet.2005.09.002
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Man WC, Ntambi JM. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J Nutr. 2001;131(9):2260–2268. doi:10.1093/jn/131.9.2260
   PubMed Web of Science ®Google Scholar
• Brown JM, Rudel LL. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol. 2010;21(3):192–197. doi:10.1097/MOL.0b013e32833854ac
   PubMed Web of Science ®Google Scholar
• Feng D, Wang Y, Mei Y, et al. Stearoyl-CoA desaturase 1 deficiency protects mice from immune-mediated liver injury. Lab Invest. 2009;89(2):222–230. doi:10.1038/labinvest.2008.105
   PubMed Web of Science ®Google Scholar
• Liu X, Miyazaki M, Flowers MT, et al. Loss of stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler Thromb Vasc Biol. 2010;30(1):31–38. doi:10.1161/ATVBAHA.109.195636
   PubMed Web of Science ®Google Scholar
• Ravaut G, Légiot A, Bergeron KF, Mounier C. Monounsaturated fatty acids in obesity‐related inflammation. Int J Mol Sci. 2021;22(1):1–22. doi:10.3390/ijms22010330
   Web of Science ®Google Scholar
• Bogie JFJ, Grajchen E, Wouters E, et al. Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain. J Exp Med. 2020;217(5). doi:10.1084/jem.20191660
   PubMed Web of Science ®Google Scholar
• Eligini S, Brioschi M, Fiorelli S, Tremoli E, Banfi C, Colli S. Human monocyte-derived macrophages are heterogenous: proteomic profile of different phenotypes. J Proteomics. 2015;124:112–123. doi:10.1016/j.jprot.2015.03.026
   PubMed Web of Science ®Google Scholar
• Agrahari V, Mandal A, Agrahari V, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6(6):735–754. doi:10.1007/s13346-016-0339-2
   PubMed Web of Science ®Google Scholar